NYSEArca - Delayed Quote USD

State Street Health Care Select Sector SPDR ETF (XLV)

143.04 -0.45 (-0.31%)
At close: May 11 at 4:00:00 PM EDT
143.33 +0.34 (+0.23%)
Pre-Market: 8:10:43 AM EDT
Trade XLV on Coinbase
Chart Range Bar
Loading chart for XLV
  • Previous Close 143.49
  • Open 143.74
  • Bid --
  • Ask 143.50 x 70000
  • Day's Range 142.68 - 145.02
  • 52 Week Range 127.35 - 160.59
  • Volume 8,481,664
  • Avg. Volume 12,521,763
  • Net Assets 37.88B
  • NAV 143.56
  • PE Ratio (TTM) 26.37
  • Yield 1.72%
  • YTD Daily Total Return -6.93%
  • Beta (5Y Monthly) 0.58
  • Expense Ratio (net) 0.08%

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

State Street Investment Management

Fund Family

Health

Fund Category

37.88B

Net Assets

1998-12-16

Inception Date

Performance Overview: XLV

View More

Trailing returns as of 5/8/2026. Category is Health.

YTD Return

XLV
6.93%
Category
2.39%
 

1-Year Return

XLV
8.87%
Category
21.31%
 

3-Year Return

XLV
4.20%
Category
6.58%
 

People Also Watch

Holdings: XLV

View More

Top 10 Holdings (59.34% of Total Assets)

SymbolCompany% Assets
Eli Lilly and Company 14.07%
Johnson & Johnson 10.52%
AbbVie Inc. 7.10%
UnitedHealth Group Incorporated 6.38%
Merck & Co., Inc. 5.15%
Amgen Inc. 3.54%
Thermo Fisher Scientific Inc. 3.42%
Intuitive Surgical, Inc. 3.09%
Gilead Sciences, Inc. 3.08%
Abbott Laboratories 3.00%

Sector Weightings

SectorXLV
Healthcare   100.00%
Real Estate   0.00%
Technology   0.00%
Utilities   0.00%
Industrials   0.00%
Energy   0.00%

Research Reports: XLV

View More
  • The mega-cap indices surged higher for a sixth straight week, and it feels like there is just no stopping this torrid advance.

    The mega-cap indices surged higher for a sixth straight week, and it feels like there is just no stopping this torrid advance. But when it seems like the market will never stop moving in a particular direction, a counter-trend move often kicks in. Indeed, it has to happen eventually.

     
  • Argus Quick Note: Weekly Stock List for 05/04/2026: Global Stock Stars

    U.S. stocks are trading near record highs - but despite the strong performance, they are being bested by global emerging stocks. A leading industrialized global stock market index, the ETF EAFE (EFA), is up 6% year to date, while the leading emerging market ETF (EEM) has gained 17%. The S&P 500 is no slacker, up 6% year to date, but still below the global emerging stocks. With continued worries over the state of the U.S. economy and some talk of stagflation, global stocks, and especially those that pay dividends, are an option for investors. The lagging U.S. markets represent a change from the recent record. Over the past five years, the S&P 500 has advanced 70% compared to a 28% gain in EAFE and a 14% gain in EEM. But the underperformance has given global stocks a valuation advantage, particularly in the area of dividends. Consider that the EAFE dividend yield of 3.35% is roughly 225 basis points higher than the comparable S&P 500 dividend yield. We think global dividend stocks continue to offer opportunity. In our view, investing in international income stocks is one way to increase portfolio diversification while reducing sensitivity to volatile U.S interest rates. That said, investing in overseas stocks carries its own set of risks, including the impact of currency exchange and geopolitical turmoil. But there are also a number of positives in this asset class for U.S. investors, including a wide selection of companies that pay dividends, robust industry diversification, and, as we have mentioned, higher yields and lower valuations. We used the sort function in the Argus screening tool using these criteria: stocks must carry and Argus BUY rating, trading just below their 52-week high, and with a dividend yield. The following is the resultant list and offers diversity in sectors and countries.

     
  • AI driving growth, raising target price to $450

    Taiwan Semiconductor Manufacturing Company Ltd., headquartered in Hsinchu, Taiwan, was founded in 1987 and pioneered the pure-play foundry or 'merchant fab' model. The company serves both integrated semiconductor producers who outsource a portion of their production as well as 'fabless' semiconductor producers who outsource all manufacturing. Taiwan Semi serves over 500 semiconductor customers, producing more than 11,500 distinct products while providing a broad range of advanced, specialty, and advanced packaging technologies.

    Rating
    Price Target
     
  • ASML Earnings: Outlook Is Magnificent, but Valuation Overshoots Our Fair Value Estimate

    ASML is the leader in lithography systems for manufacturing semiconductors with 90% market share. Lithography is the process in which a light source is used to expose circuit patterns from a photo mask onto a semiconductor wafer. Lithography allows chipmakers to increase the number of transistors on the same area of silicon, with lithography historically representing a high portion of the cost of making cutting-edge chips. ASML outsources the manufacturing of most of its parts, acting like an assembler. ASML’s largest clients are TSMC, Samsung, Intel, SK Hynix, and Micron.

    Rating
    Price Target
     

Related Tickers